News & Insights

Person

Date

  • Filter by dates

Active filters:

26.06.2023

We advised WSE-listed Pure Biologics S.A. on a PLN 12 million financing transaction

We advised WSE-listed Pure Biologics S.A. in a transaction to raise PLN 12 million in financing from a new investor, ACRX Investments Ltd. The transa...

Case studies
NEW!
We advised WSE-listed Pure Biologics S.A. on a PLN 12 million financing transaction

20.03.2023

GESSEL advises Urteste S.A. on a public placement of new issue shares and on transfer of its shares

GESSEL advises Urteste S.A. on a public placement of new issue shares and on transfer of its shares from the NewConnect alternative trading system to the main floor of t...

Case studies
GESSEL advises Urteste S.A. on a public placement of new issue shares and on transfer of its shares